Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400086012Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of vonoprazan in gastric ulcer (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Rate of ulcer reduction at week 8. Planned start Jun 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400086012.